Physician profile
Stephen R Bowen
NPI 1689688111
$2,335.67
in general payments reported to CMS, 2019-2025
39 companies · $14.45 in 2025
The $14.45 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $321 · 2021: $571 · 2022: $405 · 2023: $424 · 2024: $358 · 2025: $14.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746 · Education: $49.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.48 |
| Education | $49.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $265.41 | 2019-2022 | |
| Abbvie INC. | $211.33 | 2021-2023 | Ubrelvy |
| Pfizer INC. | $201.12 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $194.22 | 2019-2024 | Lokelma, Farxiga, Airsupra |
| Novartis Pharmaceuticals Corporation | $154.06 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.02 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $107.70 | 2022-2024 | Rexulti, Nuedexta |
| Amgen INC. | $91.31 | 2019-2024 | Evenity, Prolia |
| Dexcom, INC. | $87.01 | 2021-2023 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $78.55 | 2024 | Voquezna |
| Depuy Synthes Sales INC. | $78.33 | 2023 | Fibergraft Bg Morsels, Symphony, Confidence Spinal Cement System |
| Astellas Pharma US INC | $73.66 | 2019-2024 | Veozah |
| Lilly USA, LLC | $71.53 | 2020-2024 | Zepbound, Mounjaro |
| Allergan, INC. | $68.63 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $40.78 | 2021-2024 | Gvoke Hypopen |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.